Search Results 501-510 of 16902 for Brompheniramine

  1. Sumatriptan and naproxen (oral route) - Side effects & dosage - Mayo Clinic

    Sumatriptan is a serotonin receptor agonist that works in the brain to relieve migraine headaches. Naproxen is an NSAID. This medicine is available only with ...

  2. Neurosurgery - Clinical trials

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

  3. Peginterferon beta-1a (intramuscular route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Peginterferon beta-1a injection is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting ...

  4. Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis - Mayo Clinic

    The purpose of this study is to test the hypothesis that benralizumab will reduce exacerbation rates compared with placebo on top of standard-of-care therapy in ...

  5. Benzocaine (oral route, oromucosal route) - Side effects & dosage - Mayo Clinic

    Benzocaine is used to relieve pain and irritation caused by sore throat, sore mouth, or canker sores. This medicine is available without a prescription. Your ...

  6. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain ...

  7. Epinastine (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Epinastine ophthalmic (eye) solution is used to prevent itching of the eye caused by a condition known as allergic conjunctivitis. It works by preventing the ...

  8. Drugs and Supplements that Start with G - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “G” to learn about drug side effects, proper use and ...

  9. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

  10. Anaphylaxis - Doctors and departments - Mayo Clinic

    Anaphylaxis, a severe allergic reaction, is an emergency. Learn who's at risk, what to watch for and what to do when it occurs.